These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9637771)

  • 1. The Clk2 and Clk3 dual-specificity protein kinases regulate the intranuclear distribution of SR proteins and influence pre-mRNA splicing.
    Duncan PI; Stojdl DF; Marius RM; Scheit KH; Bell JC
    Exp Cell Res; 1998 Jun; 241(2):300-8. PubMed ID: 9637771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Clk/Sty protein kinase phosphorylates SR splicing factors and regulates their intranuclear distribution.
    Colwill K; Pawson T; Andrews B; Prasad J; Manley JL; Bell JC; Duncan PI
    EMBO J; 1996 Jan; 15(2):265-75. PubMed ID: 8617202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein kinase clk/STY is differentially regulated during erythroleukemia cell differentiation: a bias toward the skipped splice variant characterizes postcommitment stages.
    García-Sacristán A; Fernández-Nestosa MJ; Hernández P; Schvartzman JB; Krimer DB
    Cell Res; 2005 Jul; 15(7):495-503. PubMed ID: 16045812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Over-expression of SR-cyclophilin, an interaction partner of nuclear pinin, releases SR family splicing factors from nuclear speckles.
    Lin CL; Leu S; Lu MC; Ouyang P
    Biochem Biophys Res Commun; 2004 Aug; 321(3):638-47. PubMed ID: 15358154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506.
    Pilch B; Allemand E; Facompré M; Bailly C; Riou JF; Soret J; Tazi J
    Cancer Res; 2001 Sep; 61(18):6876-84. PubMed ID: 11559564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Phosphorylation of serine-arginine rich proteins--pleiotropic effect of one type posttranslational modification].
    Piekiełko-Witkowska A
    Postepy Biochem; 2006; 52(4):383-9. PubMed ID: 17536507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leucettines, a class of potent inhibitors of cdc2-like kinases and dual specificity, tyrosine phosphorylation regulated kinases derived from the marine sponge leucettamine B: modulation of alternative pre-RNA splicing.
    Debdab M; Carreaux F; Renault S; Soundararajan M; Fedorov O; Filippakopoulos P; Lozach O; Babault L; Tahtouh T; Baratte B; Ogawa Y; Hagiwara M; Eisenreich A; Rauch U; Knapp S; Meijer L; Bazureau JP
    J Med Chem; 2011 Jun; 54(12):4172-86. PubMed ID: 21615147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dual specificity protein kinase CLK3 is abundantly expressed in mature mouse spermatozoa.
    Menegay H; Moeslein F; Landreth G
    Exp Cell Res; 1999 Dec; 253(2):463-73. PubMed ID: 10585269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SR protein kinases: the splice of life.
    Stojdl DF; Bell JC
    Biochem Cell Biol; 1999; 77(4):293-8. PubMed ID: 10546892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human CDC2-like kinase 1 (CLK1): a novel target for Alzheimer's disease.
    Jain P; Karthikeyan C; Moorthy NS; Waiker DK; Jain AK; Trivedi P
    Curr Drug Targets; 2014 May; 15(5):539-50. PubMed ID: 24568585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SRPK1 and LBR protein kinases show identical substrate specificities.
    Papoutsopoulou S; Nikolakaki E; Giannakouros T
    Biochem Biophys Res Commun; 1999 Feb; 255(3):602-7. PubMed ID: 10049757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pre-mRNA splicing factors in nuclei of two-cells murine embryos].
    Bogoliubova IO; Parfenov VN
    Tsitologiia; 2000; 42(9):884-90. PubMed ID: 11077677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo regulation of alternative pre-mRNA splicing by the Clk1 protein kinase.
    Duncan PI; Stojdl DF; Marius RM; Bell JC
    Mol Cell Biol; 1997 Oct; 17(10):5996-6001. PubMed ID: 9315658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of alternative pre-mRNA splicing in vivo by pinin.
    Wang P; Lou PJ; Leu S; Ouyang P
    Biochem Biophys Res Commun; 2002 Jun; 294(2):448-55. PubMed ID: 12051732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of the catalytic subunit of protein kinase A and of HA95 in pre-mRNA splicing.
    Kvissel AK; Ørstavik S; Eikvar S; Brede G; Jahnsen T; Collas P; Akusjärvi G; Skålhegg BS
    Exp Cell Res; 2007 Aug; 313(13):2795-809. PubMed ID: 17594903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative splicing of pre-mRNAs of Arabidopsis serine/arginine-rich proteins: regulation by hormones and stresses.
    Palusa SG; Ali GS; Reddy AS
    Plant J; 2007 Mar; 49(6):1091-107. PubMed ID: 17319848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cellular localization of the murine serine/arginine-rich protein kinase CLK2 is regulated by serine 141 autophosphorylation.
    Nayler O; Schnorrer F; Stamm S; Ullrich A
    J Biol Chem; 1998 Dec; 273(51):34341-8. PubMed ID: 9852100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The alternative splicing of tau exon 10 and its regulatory proteins CLK2 and TRA2-BETA1 changes in sporadic Alzheimer's disease.
    Glatz DC; Rujescu D; Tang Y; Berendt FJ; Hartmann AM; Faltraco F; Rosenberg C; Hulette C; Jellinger K; Hampel H; Riederer P; Möller HJ; Andreadis A; Henkel K; Stamm S
    J Neurochem; 2006 Feb; 96(3):635-44. PubMed ID: 16371011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a chemical inhibitor for nuclear speckle formation: implications for the function of nuclear speckles in regulation of alternative pre-mRNA splicing.
    Kurogi Y; Matsuo Y; Mihara Y; Yagi H; Shigaki-Miyamoto K; Toyota S; Azuma Y; Igarashi M; Tani T
    Biochem Biophys Res Commun; 2014 Mar; 446(1):119-24. PubMed ID: 24569078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning of a gene (SR-A1), encoding for a new member of the human Ser/Arg-rich family of pre-mRNA splicing factors: overexpression in aggressive ovarian cancer.
    Scorilas A; Kyriakopoulou L; Katsaros D; Diamandis EP
    Br J Cancer; 2001 Jul; 85(2):190-8. PubMed ID: 11461075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.